Parnell

$50,000,000
Initial Public Offering
Co-Manager

June 2014

Agenus

Advisor

February 2014

Cancer Prevention Pharmaceuticals

EU/JP License

CPP1X/Sul to

Tillots

January 2014

Cancer Prevention Pharmaceuticals

Bridge Round

Sole Placement Agent

October 2013

Theron

Global License to

Galaxy BioTech

January 2013

Oxigene

$5 Million PIPE

Co-Placement Agent

April 2013

IGAN

Global Licensing of

IgA Protease

Shire

October 2012

Galaxy BioTech

Global Licensing of

HuGAL-F2

Roche

September 2012

Galaxy

Global Licensing of

HuGAL-FR21

Five Prime

December 2011

Cancer Prevention Pharmaceuticals

Bridge Round

Sole Placement Agent

August 2011

Altea Therapeutics

Advisor
2010-2011

Threshold Pharmaceuticals

Advisor
2009-2011

Bellus Health

Global license to

Celtic Pharma

May 2010

Inhibitex

Advisor
2010

Emergent Biosolutions

Advisor
2010

Threshold Pharmaceuticals

$35 Million PIPE

Lead Placement Agent

October 2009

Facet Biotech

Advisor
2009

Adventrix Pharmaceuticals

Advisor
2009

Bradmer Pharmaceuticals

Advisor
2008-2009

Navitas

Sale to

Gilead

May 2008

Download our presentation
PDF

Get a digital copy of our PDF presentation

Download PDF